Investor Tips
New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt.

Articles You May Like

83% of Gen Z say they’re job hoppers. Here’s how to handle old workplace retirement funds
LVMH boss Bernard Arnault under investigation in Paris over Russian oligarch transactions
A recession is coming and investors should be defensive, TCW CEO says
Today’s graduates make almost $10,000 less than their parents, after adjusting for inflation
Stocks making the biggest moves before the bell: Nike, Blue Apron, Bumble and more